MassMutual Private Wealth & Trust’s Syndax Pharmaceuticals SNDX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55K	Hold	71	–	–	﹤0.01%	2069
2026 Q1	$1.66K	Hold	71	–	–	﹤0.01%	2015
2025 Q4	$1.49K	Hold	71	–	–	﹤0.01%	2068
2025 Q3	$1.09K	Hold	71	–	–	﹤0.01%	2129
2025 Q2	$665	Buy	71 +25	+54%	+$275	﹤0.01%	2197
2025 Q1	$565	Sell	46 -19	-29%	-$268	﹤0.01%	2215
2024 Q4	$859	Buy	65 +19	+41%	+$325	﹤0.01%	2052
2024 Q3	$886	Hold	46	–	–	﹤0.01%	1885
2024 Q2	$944	Sell	46 -10	-18%	-$209	﹤0.01%	1825
2024 Q1	$1.33K	Buy	56 +10	+22%	+$223	﹤0.01%	1641
2023 Q4	$994	Sell	46 -10	-18%	-$154	﹤0.01%	1683
2023 Q3	$813	Sell	56 -5	-8%	-$95	﹤0.01%	1737
2023 Q2	$1.28K	Buy	61 +5	+9%	+$104	﹤0.01%	1596
2023 Q1	$1.18K	Hold	56	–	–	﹤0.01%	1553
2022 Q4	$1K	Hold	56	–	–	﹤0.01%	1543
2022 Q3	$1K	Buy	56 +19	+51%	+$426	﹤0.01%	1519
2022 Q2	$1K	Hold	37	–	–	﹤0.01%	1410
2022 Q1	$1K	Buy	+37	New	+$623	﹤0.01%	1420

Other funds holding SNDX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

VIG

Vienna Insurance Group Warsaw, Poland $381M AUM 105.39% 1-Year Est. Return

TIP

Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

MassMutual Private Wealth & Trust's SNDX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 71 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2069.

MassMutual Private Wealth & Trust first reported a position in SNDX in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.66K in Q1 2026. 36 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

MassMutual Private Wealth & Trust held 71 shares of Syndax Pharmaceuticals worth $1.55K as of Q2 2026.
MassMutual Private Wealth & Trust left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
Syndax Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2069 holding.
MassMutual Private Wealth & Trust first reported a position in Syndax Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
MassMutual Private Wealth & Trust's Syndax Pharmaceuticals position peaked at $1.66K in Q1 2026.
36 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.